Allopurinol and Primary myelofibrosis - a phase IV clinical study of FDA data
Primary myelofibrosis is found among people who take Allopurinol, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Allopurinol and have Primary myelofibrosis. It is created by eHealthMe based on reports of 164,051 people who have side effects when taking Allopurinol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
164,051 people reported to have side effects when taking Allopurinol.
Among them, 171 people (0.1%) have Primary myelofibrosis.
What is Allopurinol?
Allopurinol has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 166,626 Allopurinol users for its effectiveness, alternative drugs and more.
What is Primary myelofibrosis?
Primary myelofibrosis (primary disorder of the bone marrow) is found to be associated with 1,084 drugs and 764 conditions by eHealthMe.
Number of Allopurinol and Primary myelofibrosis reports submitted per year:
Time on Allopurinol when people have Primary myelofibrosis *:
Gender of people who have Primary myelofibrosis when taking Allopurinol*:
Age of people who have Primary myelofibrosis when taking Allopurinol *:
Common drugs people take besides Allopurinol *:
Common side effects people have besides Primary myelofibrosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Allopurinol and have Primary myelofibrosis?Check whether Primary myelofibrosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Primary myelofibrosis and when was it recovered:
Expand to all the drugs that have ingredients of allopurinol:
Alternative drugs to, pros and cons of Allopurinol:
- Allopurinol (166,626 reports)
Common Allopurinol side effects:
- Diarrhea: 9,701 reports
- Fatigue (feeling of tiredness): 9,558 reports
- Breathing difficulty: 8,893 reports
- Weakness: 8,160 reports
- Fever: 8,048 reports
- Pneumonia: 7,430 reports
- Thrombocytopenia (decrease of platelets in blood): 7,366 reports
Browse all side effects of Allopurinol:a b c d e f g h i j k l m n o p q r s t u v w x y z
Primary myelofibrosis treatments and more:
- Primary myelofibrosis (35,056 reports)
COVID vaccines that are related to Primary myelofibrosis:
- Primary myelofibrosis in Moderna COVID Vaccine
- Primary myelofibrosis in Pfizer BioNTech Covid Vaccine
- Primary myelofibrosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Primary myelofibrosis:
- Jakafi: 776 reports
- Aspirin: 275 reports
- Hydrea: 264 reports
- Lopurin: 171 reports
- Allopurinol: 171 reports
- Exjade: 156 reports
- Nplate: 155 reports
- Prednisone: 152 reports
- Hydroxyurea: 141 reports
- Prednisolone: 141 reports
All the drugs that are associated with Primary myelofibrosis:
- Primary myelofibrosis (1,084 drugs)
Common conditions associated with Primary myelofibrosis:
- High blood pressure: 137 reports
- Idiopathic thrombocytopenic purpura (itp): 108 reports
All the conditions that are associated with Primary myelofibrosis:
- Primary myelofibrosis (764 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on allopurinol (the active ingredients of Allopurinol) and Allopurinol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Meticorten and Actemra drug interaction - 6 seconds ago
- Bactrim and Muscle Spasms - 10 seconds ago
- Stiolto Respimat and Muscle Aches - 17 seconds ago
- Mycophenolate Mofetil and Pyogenic Liver Abscess - 18 seconds ago
- Fragmin and Abdominal Pain Upper - 34 seconds ago
- Acetylsalicylic Acid and Mucosal Dryness - 35 seconds ago
- Premarin and Impacted Fracture - 42 seconds ago
- Rydapt and Klebsiella Infection - 47 seconds ago
- Pirfenidone and Prozac drug interaction - 50 seconds ago
- Acyclovir and Daurismo drug interaction - 58 seconds ago